Login / Signup

Immunological and Haematological Relevance of Helminths and Mycobacterium tuberculosis Complex Coinfection among Newly Diagnosed Pulmonary Tuberculosis Patients from Bobo-Dioulasso, Burkina Faso.

Diakourga Arthur DjibougouGloria Ivy MensahAchille KaboréInoussa ToéLeon Tinnoga SawadogoPalpouguini Felix LompoAmariane M M KoneHervé HienClement Ziemle MedaAdjima CombaryBassirou BonfohKennedy Kwasi AddoAdrien Marie-Gaston BelemRoch Kounbobr DabireJonathan HoffmannMatthieu PerreauPotiandi Serge Diagbouga
Published in: Biomedicines (2024)
The effect of helminthiasis on host immunity is a neglected area of research, particularly in tuberculosis (TB) infection. This study aimed to evaluate the effect of helminthiasis on immunological and haematological parameters in newly diagnosed TB patients in Bobo-Dioulasso. After all biological analyses, we formed three subpopulations: group 1 ( n = 82), as control, were participants without helminthic or Mycobacterium tuberculosis complex infection ( Mtb -/Helm-), group 2 ( n = 73) were TB patients without helminthic infection ( Mtb +/Helm-), and group 3 ( n = 22) were TB patients with helminthic infection ( Mtb +/Helm+). The proportion of helminth coinfection was 23.16% (22/95) in TB patients, and Schistosoma mansoni infection was found in 77.3% (17/22) cases of helminthiasis observed in this study. A low CD4 T cell count and a low CD4:CD8 ratio were significantly associated with concomitant infection with helminths and the Mtb complex ( Mtb +/Helm+) compared to the other groups ( p < 0.05). However, there was no statistically significant difference in the CD8 median among the three participating groups ( p > 0.05). Lymphopenia, monocytosis, thrombocytosis, and hypochromic microcytic anaemia were the haematological defects observed in the Mtb+ /Helm+ and Mtb+ /Helm- patients. Exploring these types of immune-haematological biomarkers would be a valuable aid in diagnosing and a better follow-up and monitoring of the tuberculosis-helminthiasis coinfection.
Keyphrases
  • mycobacterium tuberculosis
  • pulmonary tuberculosis
  • newly diagnosed
  • end stage renal disease
  • ejection fraction
  • chronic kidney disease
  • peritoneal dialysis
  • patient reported outcomes
  • hepatitis c virus